{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T10:01:20Z","timestamp":1726480880806},"reference-count":60,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gastroenterology Clinics of North America"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1016\/j.gtc.2008.02.002","type":"journal-article","created":{"date-parts":[[2008,5,21]],"date-time":"2008-05-21T15:14:27Z","timestamp":1211382867000},"page":"461-478","source":"Crossref","is-referenced-by-count":6,"title":["Diagnosis and Treatment of Autoimmune Hepatitis"],"prefix":"10.1016","volume":"37","author":[{"given":"Bruce A.","family":"Luxon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gtc.2008.02.002_bib1","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/00365529850166284","article-title":"Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population","volume":"33","author":"Boberg","year":"1998","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.gtc.2008.02.002_bib2","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/hep.510280306","article-title":"Acute hepatic allograft rejection: incidence, risk factors, and impact on outcome","volume":"28","author":"Wiesner","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.gtc.2008.02.002_bib3","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3810\/pgm.2003.07.1455","article-title":"Autoimmune hepatitis. Making sense of all those antibodies","volume":"114","author":"Luxon","year":"2003","journal-title":"Postgrad Med"},{"key":"10.1016\/j.gtc.2008.02.002_bib4","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11894-006-0068-7","article-title":"Autoimmune hepatitis: diagnosis, treatment, and prognosis","volume":"8","author":"Luxon","year":"2006","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.gtc.2008.02.002_bib5","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/hep.21074","article-title":"Distinctive clinical phenotype and treatment outcome of type 1 autoimmune hepatitis in the elderly","volume":"43","author":"Czaja","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.gtc.2008.02.002_bib6","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S0016-5085(19)33223-8","article-title":"Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis","volume":"63","author":"Soloway","year":"1972","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2008.02.002_bib7","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0140-6736(73)92125-9","article-title":"Controlled trial of prednisone and azathioprine in active chronic hepatitis","volume":"1","author":"Murray-Lyon","year":"1973","journal-title":"Lancet"},{"key":"10.1016\/j.gtc.2008.02.002_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-2008-1040641","article-title":"Natural history, clinical features, and treatment of autoimmune hepatitis","volume":"4","author":"Czaja","year":"1984","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.gtc.2008.02.002_bib9","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/hep.20732","article-title":"Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcome","volume":"42","author":"Feld","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.gtc.2008.02.002_bib10","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1053\/jhep.2002.34944","article-title":"Diagnosis and treatment of autoimmune hepatitis","volume":"36","author":"Czaja","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.gtc.2008.02.002_bib11","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/BF01076196","article-title":"Severe chronic active liver disease. Prognostic significance of initial morphologic patterns","volume":"22","author":"Schalm","year":"1977","journal-title":"Am J Dig Dis"},{"key":"10.1016\/j.gtc.2008.02.002_bib12","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2165\/00003495-199957010-00005","article-title":"Drug therapy in the management of type 1 autoimmune hepatitis","volume":"57","author":"Czaja","year":"1999","journal-title":"Drugs"},{"key":"10.1016\/j.gtc.2008.02.002_bib13","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.gtc.2008.02.002_bib14","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00004836-200207000-00016","article-title":"Prognosis of symptomatic versus asymptomatic autoimmune hepatitis: a study of 68 patients","volume":"35","author":"Kogan","year":"2002","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.gtc.2008.02.002_bib15","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/0016-5085(84)90186-0","article-title":"Development and prognosis of histologic cirrhosis in corticosteroid-treated hepatitis B surface antigen-negative chronic active hepatitis","volume":"87","author":"Davis","year":"1984","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2008.02.002_bib16","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1111\/j.1572-0241.2004.30457.x","article-title":"Factors predicting relapse and poor outcome in type I autoimmune hepatitis: role of cirrhosis development, patterns of transaminases during remission and plasma cell activity in the liver biopsy","volume":"99","author":"Verma","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gtc.2008.02.002_bib17","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1053\/gast.1996.v110.pm8608895","article-title":"Prognosis of histological cirrhosis in type 1 autoimmune hepatitis","volume":"110","author":"Roberts","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2008.02.002_bib18","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S1089-3261(02)00028-4","article-title":"Treatment strategies in autoimmune hepatitis","volume":"6","author":"Czaja","year":"2002","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.gtc.2008.02.002_bib19","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1002\/hep.20932","article-title":"In type 1 autoimmune hepatitis, is cirrhosis at presentation or follow-up associated with a poorer outcome?","volume":"42","author":"Verma","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.gtc.2008.02.002_bib20","doi-asserted-by":"crossref","first-page":"S630","DOI":"10.1111\/j.1572-0241.2006.00979.x","article-title":"Treatment strategies for autoimmune hepatitis","volume":"101","author":"Heathcote","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gtc.2008.02.002_bib21","doi-asserted-by":"crossref","first-page":"981","DOI":"10.7326\/0003-4819-127-11-199712010-00006","article-title":"Reversibility of hepatic fibrosis in autoimmune hepatitis","volume":"127","author":"Dufour","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.gtc.2008.02.002_bib22","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1002\/hep.20235","article-title":"Progressive fibrosis during corticosteroid therapy of autoimmune hepatitis","volume":"39","author":"Czaja","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.gtc.2008.02.002_bib23","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/hep.1840180435","article-title":"Meeting report: international autoimmune hepatitis group","volume":"18","author":"Johnson","year":"1993","journal-title":"Hepatology"},{"key":"10.1016\/j.gtc.2008.02.002_bib24","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1365-3083.2007.01967.x","article-title":"Autoimmune hepatitis in Brazil: an overview","volume":"66","author":"Goldberg","year":"2007","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.gtc.2008.02.002_bib25","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1136\/gut.49.4.589","article-title":"Autoimmune hepatitis and its variant syndromes","volume":"49","author":"Ben-Ari","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.gtc.2008.02.002_bib26","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/hep.510280210","article-title":"Frequency and nature of the variant syndromes of autoimmune liver disease","volume":"28","author":"Czaja","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.gtc.2008.02.002_bib27","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1053\/jhep.2001.27562","article-title":"Autoimmune hepatitis with incidental histologic features of bile duct injury","volume":"34","author":"Czaja","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.gtc.2008.02.002_bib28","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1053\/jhep.2000.7878","article-title":"Autoimmune cholangitis within the spectrum of autoimmune liver disease","volume":"31","author":"Czaja","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.gtc.2008.02.002_bib29","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1016\/0016-5085(93)91081-R","article-title":"Sensitivity, specificity, and predictability of biopsy interpretations in chronic hepatitis","volume":"105","author":"Czaja","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2008.02.002_bib30","first-page":"1206","article-title":"The validity and importance of subtypes in autoimmune hepatitis: a point of view","volume":"90","author":"Czaja","year":"1995","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gtc.2008.02.002_bib31","first-page":"485","article-title":"Anti-mitochondrial type 5 antibodies and anti-cardiolipin antibodies in systemic lupus erythematosus and auto-immune diseases","volume":"69","author":"Meyer","year":"1987","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.gtc.2008.02.002_bib32","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1023\/A:1018809431189","article-title":"Antinuclear antibodies and patterns of nuclear immunofluorescence in type 1 autoimmune hepatitis","volume":"42","author":"Czaja","year":"1997","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.gtc.2008.02.002_bib33","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0168-8278(99)80096-8","article-title":"Behavior and significance of autoantibodies in type 1 autoimmune hepatitis","volume":"30","author":"Czaja","year":"1999","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.gtc.2008.02.002_bib34","doi-asserted-by":"crossref","first-page":"4394","DOI":"10.3748\/wjg.v13.i32.4394","article-title":"Fulminant hepatic failure in a case of autoimmune hepatitis in hepatitis C during peg-interferon-alpha 2b plus ribavirin treatment","volume":"13","author":"Kogure","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.gtc.2008.02.002_bib35","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/hep.1840120120","article-title":"Patients with type II autoimmune hepatitis express functionally intact cytochrome P-450 db1 that is inhibited by LKM-1 autoantibodies in vitro but not in vivo","volume":"12","author":"Manns","year":"1990","journal-title":"Hepatology"},{"key":"10.1016\/j.gtc.2008.02.002_bib36","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1172\/JCI115443","article-title":"LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase","volume":"88","author":"Manns","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1016\/j.gtc.2008.02.002_bib37","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/0016-5085(92)91518-9","article-title":"Frequency and significance of antibodies to liver\/kidney microsome type 1 in adults with chronic active hepatitis","volume":"103","author":"Czaja","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2008.02.002_bib38","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1053\/jhep.2002.34944","article-title":"American Association for the Study of Liver Disease: diagnosis and treatment of autoimmune hepatitis","volume":"36","author":"Czaja","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.gtc.2008.02.002_bib39","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/S0140-6736(84)91167-X","article-title":"Antibodies to liver-specific protein predict outcome of treatment withdrawal in autoimmune chronic active hepatitis","volume":"2","author":"McFarlane","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.gtc.2008.02.002_bib40","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0168-8278(05)80176-X","article-title":"Autoantibodies against the human asialoglycoprotein receptor: effects of therapy in autoimmune and virus-induced chronic active hepatitis","volume":"19","author":"Treichel","year":"1993","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.gtc.2008.02.002_bib41","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/S0140-6736(00)02166-8","article-title":"Identification of target antigen for SLA\/LP autoantibodies in autoimmune hepatitis","volume":"355","author":"Wies","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.gtc.2008.02.002_bib42","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0046-8177(72)80072-8","article-title":"Chronic active liver disease. The range of histologic lesions, their response to treatment, and evolution","volume":"3","author":"Baggenstoss","year":"1972","journal-title":"Hum Pathol"},{"key":"10.1016\/j.gtc.2008.02.002_bib43","first-page":"331","article-title":"Prednisone for chronic active hepatitis: pharmacokinetics and serum binding in patients with chronic active hepatitis and steroid major side effects","volume":"6","author":"Uribe","year":"1984","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.gtc.2008.02.002_bib44","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1136\/gut.16.11.876","article-title":"Prednisone for chronic active liver disease: dose titration, standard dose, and combination with azathioprine compared","volume":"16","author":"Summerskill","year":"1975","journal-title":"Gut"},{"key":"10.1016\/j.gtc.2008.02.002_bib45","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/hep.1840040409","article-title":"Complete resolution of inflammatory activity following corticosteroid treatment of HBsAg-negative chronic active hepatitis","volume":"4","author":"Czaja","year":"1984","journal-title":"Hepatology"},{"key":"10.1016\/j.gtc.2008.02.002_bib46","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/0016-5085(81)90126-8","article-title":"Laboratory assessment of severe chronic active liver disease during and after corticosteroid therapy: correlation of serum transaminase and gamma globulin levels with histologic features","volume":"80","author":"Czaja","year":"1981","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2008.02.002_bib47","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/hep.1840030510","article-title":"Relapse following treatment withdrawal in patients with autoimmune chronic active hepatitis","volume":"3","author":"Hegarty","year":"1983","journal-title":"Hepatology"},{"key":"10.1016\/j.gtc.2008.02.002_bib48","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1111\/j.1572-0241.2007.01153.x","article-title":"Improving the end point of corticosteroid therapy in type 1 autoimmune hepatitis to reduce the frequency of relapse","volume":"102","author":"Montano-Loza","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gtc.2008.02.002_bib49","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/j.1572-0241.2007.01147.x","article-title":"Remission in autoimmune hepatitis: what is it, and can it ever be achieved?","volume":"102","author":"Al-Chalabi","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gtc.2008.02.002_bib50","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1136\/gut.48.1.97","article-title":"Management and outcome of pregnancy in autoimmune hepatitis","volume":"48","author":"Heneghan","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.gtc.2008.02.002_bib51","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1111\/j.1572-0241.2002.07124.x","article-title":"Improvement of autoimmune hepatitis during pregnancy followed by flare-up after delivery","volume":"97","author":"Buchel","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gtc.2008.02.002_bib52","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/j.1572-0241.2006.00479.x","article-title":"Pregnancy in autoimmune hepatitis: outcome and risk factors","volume":"101","author":"Schramm","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gtc.2008.02.002_bib53","first-page":"519","article-title":"Pregnancy in chronic active hepatitis","volume":"48","author":"Steven","year":"1979","journal-title":"Q J Med"},{"key":"10.1016\/j.gtc.2008.02.002_bib54","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1097\/00007890-199812270-00013","article-title":"Outcome of autoimmune hepatitis after liver transplantation","volume":"66","author":"Prados","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.gtc.2008.02.002_bib55","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/00007890-199201000-00027","article-title":"Disease recurrence and rejection following liver transplantation for autoimmune chronic active liver disease","volume":"53","author":"Wright","year":"1992","journal-title":"Transplantation"},{"key":"10.1016\/j.gtc.2008.02.002_bib56","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1136\/gut.52.6.893","article-title":"A 10 year follow up study of patients transplanted for autoimmune hepatitis: histological recurrence precedes clinical and biochemical recurrence","volume":"52","author":"Duclos-Vallee","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.gtc.2008.02.002_bib57","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1053\/jhep.2000.9077","article-title":"Liver transplantation for autoimmune hepatitis: a long-term pathologic study","volume":"32","author":"Ayata","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.gtc.2008.02.002_bib58","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1053\/jlts.2001.21449","article-title":"Recurrent autoimmune hepatitis after orthotopic liver transplantation","volume":"7","author":"Gonzalez-Koch","year":"2001","journal-title":"Liver Transpl"},{"key":"10.1016\/j.gtc.2008.02.002_bib59","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/00007890-199907270-00016","article-title":"Recurrence of autoimmune hepatitis after liver transplantation","volume":"68","author":"Milkiewicz","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.gtc.2008.02.002_bib60","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1002\/lt.20910","article-title":"Recurrence of autoimmune liver disease after liver transplantation: a systematic review","volume":"12","author":"Gautam","year":"2006","journal-title":"Liver Transpl"}],"container-title":["Gastroenterology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889855308000174?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889855308000174?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,11]],"date-time":"2019-05-11T11:20:22Z","timestamp":1557573622000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889855308000174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":60,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["S0889855308000174"],"URL":"https:\/\/doi.org\/10.1016\/j.gtc.2008.02.002","relation":{},"ISSN":["0889-8553"],"issn-type":[{"type":"print","value":"0889-8553"}],"subject":[],"published":{"date-parts":[[2008,6]]}}}